These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 1115110

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486.
    Luukkainen T, Heikinheimo O, Haukkamaa M, Lähteenmäki P.
    Fertil Steril; 1988 Jun; 49(6):961-3. PubMed ID: 3371492
    [Abstract] [Full Text] [Related]

  • 4. Effect of short-term cyclic administration of cyproterone acetate on pituitary-ovarian function in the human.
    Kumari GI, Das RP, Madoiya KK, Jain AK, Roy S.
    Fertil Steril; 1977 Nov; 28(11):1168-74. PubMed ID: 562781
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
    Kekkonen R, Alfthan H, Haukkamaa M, Heikinheimo O, Luukkainen T, Lähteenmäki P.
    Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
    [Abstract] [Full Text] [Related]

  • 7. Intravenous infusion of prostaglandin F2alpha in the mid-luteal phase of the normal human menstrual cycle.
    Jewelewicz R, Cantor B, Dyrenfurth I, Warren MP, Vande Wiele RL.
    Prostaglandins; 1972 Jun; 1(6):443-51. PubMed ID: 4660079
    [No Abstract] [Full Text] [Related]

  • 8. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
    Croxatto HB, Salvatierra AM, Romero C, Spitz IM.
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
    [Abstract] [Full Text] [Related]

  • 9. Induction of premature menstruation with catatoxic steroids.
    Bolch OH, Warren JC.
    Am J Obstet Gynecol; 1971 Dec 15; 111(8):1107-10. PubMed ID: 5129565
    [Abstract] [Full Text] [Related]

  • 10. Effect of daily administration of 0.5 mg. of chlormadinone acetate on plasma levels of follicle-stimulating hormone, luteinizing hormone, and progesterone during the menstrual cycle.
    Saunders DM, Marcus SL, Saxena BB, Beling CG, Connell EB.
    Fertil Steril; 1971 May 15; 22(5):332-44. PubMed ID: 4102481
    [Abstract] [Full Text] [Related]

  • 11. Induction of relaxin secretion in nonpregnant women by human chorionic gonadotropin.
    Quagliarello J, Goldsmith L, Steinetz B, Lustig DS, Weiss G.
    J Clin Endocrinol Metab; 1980 Jul 15; 51(1):74-7. PubMed ID: 7380995
    [Abstract] [Full Text] [Related]

  • 12. Delayed endometrial maturation induced by daily administration of the antiprogestin RU 486: a potential new contraceptive strategy.
    Batista MC, Cartledge TP, Zellmer AW, Merino MJ, Axiotis C, Loriaux DL, Nieman LK.
    Am J Obstet Gynecol; 1992 Jul 15; 167(1):60-5. PubMed ID: 1442957
    [Abstract] [Full Text] [Related]

  • 13. The effect of vaginally administered prostaglandin F2alpha on corpus luteum function.
    Bolognese RJ, Corson SL.
    Am J Obstet Gynecol; 1973 Sep 15; 117(2):240-5. PubMed ID: 4728875
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of ovulation by low-dose mifepristone (RU 486).
    Ledger WL, Sweeting VM, Hillier H, Baird DT.
    Hum Reprod; 1992 Aug 15; 7(7):945-50. PubMed ID: 1331167
    [Abstract] [Full Text] [Related]

  • 15. Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women.
    Roseff SJ, Kettel LM, Rivier J, Burger HG, Baulieu E, Yen SS.
    Fertil Steril; 1990 Nov 15; 54(5):805-10. PubMed ID: 2226914
    [Abstract] [Full Text] [Related]

  • 16. Suppression of ovarian function with the transdermally given synthetic progestin ST 1435.
    Laurikka-Routti M, Haukkamaa M, Lähteenmäki P.
    Fertil Steril; 1992 Oct 15; 58(4):680-4. PubMed ID: 1426309
    [Abstract] [Full Text] [Related]

  • 17. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
    Garzo VG, Liu J, Ulmann A, Baulieu E, Yen SS.
    J Clin Endocrinol Metab; 1988 Mar 15; 66(3):508-17. PubMed ID: 2832438
    [Abstract] [Full Text] [Related]

  • 18. Early luteal phase treatment with mifepristone (RU 486) for fertility regulation.
    Gemzell-Danielsson K, Swahn ML, Svalander P, Bygdeman M.
    Hum Reprod; 1993 Jun 15; 8(6):870-3. PubMed ID: 8345076
    [Abstract] [Full Text] [Related]

  • 19. Effect of prostaglandin F2alpha on the luteal phase of the cycle in nonpregnant women.
    Arrata WS, Chatterton RT.
    Am J Obstet Gynecol; 1974 Dec 01; 120(7):954-9. PubMed ID: 4429112
    [Abstract] [Full Text] [Related]

  • 20. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
    Liu JH, Garzo G, Morris S, Stuenkel C, Ulmann A, Yen SS.
    J Clin Endocrinol Metab; 1987 Dec 01; 65(6):1135-40. PubMed ID: 2824550
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.